These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 719635)

  • 1. Effect of methylprednisolone on cell proliferation in C3H/HeJ spontaneous mammary tumors.
    Braunschweiger PG; Stragand JJ; Schiffer LM
    Cancer Res; 1978 Dec; 38(12):4510-4. PubMed ID: 719635
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of methylprednisolone on the cell kinetic response of C3H/HeJ mammary tumors to cyclophosphamide and adriamycin.
    Braunschweiger PG; Schiffer LM
    Cancer Res; 1979 Oct; 39(10):3812-5. PubMed ID: 476617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative effects of corticosteroids in C3H/HeJ Mammary tumors and implications for sequential combination chemotherapy.
    Braunschweiger PG; Schiffer LM
    Cancer Res; 1981 Sep; 41(9 Pt 1):3324-30. PubMed ID: 7260899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sequence of administration of methotrexate, leucovorin, and 5-fluorouracil on mammary tumor growth and survival in syngeneic C3H mice.
    Heppner GH; Calabresi P
    Cancer Res; 1977 Dec; 37(12):4580-3. PubMed ID: 303542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
    Heppner GH; Dexter DL; DeNucci T; Miller FR; Calabresi P
    Cancer Res; 1978 Nov; 38(11 Pt 1):3758-63. PubMed ID: 698935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic implications of cell kinetic changes after cyclophosphamide treatment in "spontaneous" and "transplantable" mammary tumors.
    Branunschweiger PG; Schiffer LM
    Cancer Treat Rep; 1978 May; 62(5):727-36. PubMed ID: 657158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of maltose tetrapalmitate on tumor vascularization and tumor growth.
    Benrezzak O; Bissonnette E; Madarnas P; Nigam VN
    Anticancer Res; 1989; 9(6):1815-8. PubMed ID: 2483306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures.
    Miller BE; Miller FR; Heppner GH
    Cancer Res; 1985 Sep; 45(9):4200-5. PubMed ID: 4028010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell kinetics after vincristine treatment of C3H/He spontaneous mammary tumors: implications for therapy.
    Braunschweiger PG; Schiffer LM
    J Natl Cancer Inst; 1978 May; 60(5):1043-8. PubMed ID: 642025
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of Corynebacterium parvum in combination with 5-fluorouracil, L-phenylalanine mustard, or methotrexate on the inhibition of tumor growth.
    Fisher B; Rubin H; Saffer E; Wolmark N
    Cancer Res; 1976 Aug; 36(8):2714-9. PubMed ID: 1277181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic consequences of antitumour drug interactions: methotrexate and 5-fluorouracil in the chemotherapy of C3H mice with transplanted mammary adenocarcinoma.
    Brown I; Ward HW
    Cancer Lett; 1978 Nov; 5(5):291-7. PubMed ID: 728887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fifty-five percent complete remission of mammary carcinoma in mice with 5-fluorouracil and chloroquine.
    Shoemaker JP
    Cancer Res; 1978 Sep; 38(9):2700-2. PubMed ID: 679173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remissions of mammary adenocarcinoma in hypothyroid mice given 5-fluorouracil and chloroquine phosphate.
    Shoemaker JP; Dagher RK
    J Natl Cancer Inst; 1979 Jun; 62(6):1575-8. PubMed ID: 286128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic perturbation of the tumor ecosystem in reconstructed heterogeneous mouse mammary tumors.
    Miller BE; Miller FR; Heppner GH
    Cancer Res; 1989 Jul; 49(14):3747-53. PubMed ID: 2736515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adriamycin on the cell kinetics of 13762 rat mammary tumors and implications for therapy.
    Braunschweiger PG; Schiffer LM
    Cancer Treat Rep; 1980; 64(2-3):293-300. PubMed ID: 7407764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of proteolytic enzymes on mammary tumor growth: in vitro and in vivo suppression and cellular death of tumor cells.
    Belzer CA; Cavon JF
    J Exp Pathol; 1990; 5(3):97-110. PubMed ID: 2094775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kinetics of the cell proliferation of murine mammary adenocarcinoma under the influence of methylcobalamine].
    Golenko OD; Arsenian FG; Miasishcheva NV; Sof'ina ZP
    Biull Eksp Biol Med; 1980 Feb; 89(2):185-7. PubMed ID: 7370419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 3,5,3'-triiodo-L-thyronine on the incidence and growth kinetics of spontaneous mammary tumors in C3H/HeN mice.
    Sellitti DF; Tseng YC; Latham KR
    Cancer Res; 1981 Dec; 41(12 Pt 1):5015-9. PubMed ID: 7307003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.
    Grau C; Overgaard J
    Cancer Chemother Pharmacol; 1992; 30(4):277-80. PubMed ID: 1643695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of metronidazole on the C3H/HeJ mouse and growth of the C3HBA mammary adenocarcinoma.
    Inch WR; McCredie JA; Haynes MJ; Sutherland RM
    Growth; 1977 Mar; 41(1):15-23. PubMed ID: 858527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.